Chemplast Sanmar Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar reported FY2026 standalone revenue of Rs 2,170 crore, down 9% from Rs 2,388 crore in FY2025. The company recorded a standalone net loss of Rs 1,883 crore primarily due to a Rs 898 crore impairment provision (exceptional item) on its wholly owned subsidiary CCVL engaged in Suspension PVC business. The impairment was triggered by regulatory changes including dropping of anti-dumping duty expected on S-PVC, removal of customs duty on imports, significant price decline from cheap imports, and raw material volatility due to Middle East crisis. Consolidated revenue stood at Rs 4,224 crore with consolidated net profit of Rs 145 crore. Auditors BSR & Co. LLP issued an unmodified opinion. The board also constituted a committee of Independent Directors to evaluate strategic priorities, potential reorganizations, and M&A opportunities. No dividend was recommended for FY2025-26.
The massive Rs 898 crore impairment signals significant stress in the PVC subsidiary but the consolidated results remain profitable. The formation of a strategic committee suggests the company is actively exploring options to address challenges in its commodity chemicals business.